作者: WAG 時(shí)間: 2025-3-21 21:49 作者: Insul島 時(shí)間: 2025-3-22 02:17
Chemotherapy and Interactions with Combination Antiretroviral Therapy,cART in relation to antineoplastic agents and potential pharmacological interactions between cART and antineoplastic agents and consider how to combine cART and antineoplastic agents in patients with HIV.作者: 要塞 時(shí)間: 2025-3-22 04:44
he latest evidence on the efficacy of different treatment ap.This book presents a general introduction to and review of HIV-associated hematological malignancies, with a special focus on practical management issues.?Each of the relevant malignancies is addressed individually, with an overview of tre作者: Sinus-Rhythm 時(shí)間: 2025-3-22 11:43 作者: miscreant 時(shí)間: 2025-3-22 13:40 作者: 野蠻 時(shí)間: 2025-3-22 20:03
https://doi.org/10.1007/978-3-030-02523-6cART in relation to antineoplastic agents and potential pharmacological interactions between cART and antineoplastic agents and consider how to combine cART and antineoplastic agents in patients with HIV.作者: 壯觀的游行 時(shí)間: 2025-3-23 00:54 作者: 摘要 時(shí)間: 2025-3-23 01:52
Concept Of The Knowledge Of Gody in patients infected with HIV, though cases have also been reported in patients with advanced age or poor immune function. Here we examine the epidemiology, pathogenesis, diagnosis, and treatments for PBL and future directions to gain insight on how to better understand and manage this entity in patients infected with HIV.作者: Insatiable 時(shí)間: 2025-3-23 09:06
Italy, Spain and the Rest of Europeserves. New areas of endeavor include high-dose chemotherapy coupled to autologous and allogeneic stem cell transplantation. Advances in the field of “HIV cure research” also offer the opportunity to eradicate not only AML but also HIV infection through the use of CCR-5-deficient hematopoietic stem cells.作者: META 時(shí)間: 2025-3-23 12:43
AIDS-Related Plasmablastic Lymphoma,y in patients infected with HIV, though cases have also been reported in patients with advanced age or poor immune function. Here we examine the epidemiology, pathogenesis, diagnosis, and treatments for PBL and future directions to gain insight on how to better understand and manage this entity in patients infected with HIV.作者: custody 時(shí)間: 2025-3-23 14:07 作者: characteristic 時(shí)間: 2025-3-23 19:59
Introduction: A Political Question, developing hematological malignancies, PWA are also at elevated risk of death than their counterparts in the general population. A persisting, although narrowing, gap in cancer survival between PWA and non-PWA is still observed.作者: 無(wú)法解釋 時(shí)間: 2025-3-24 00:51
The Conception of God in the Later Royceissues. PEL may also present as “extracavitary mass lesions without effusions”, commonly in the gastrointestinal tract. This is referred to as the solid variant of PEL which shares morphologic, immunophenotypic, and virologic features with classic PEL, allowing the recognition of these entities as part of the spectrum of PEL.作者: RAFF 時(shí)間: 2025-3-24 03:09 作者: intertwine 時(shí)間: 2025-3-24 10:12 作者: Truculent 時(shí)間: 2025-3-24 13:08
HIV-Associated Primary Effusion Lymphoma,issues. PEL may also present as “extracavitary mass lesions without effusions”, commonly in the gastrointestinal tract. This is referred to as the solid variant of PEL which shares morphologic, immunophenotypic, and virologic features with classic PEL, allowing the recognition of these entities as part of the spectrum of PEL.作者: 不可磨滅 時(shí)間: 2025-3-24 14:52
Infection Prophylaxis,μl and systemic antifungal prophylaxis may be given to patients with CD4 counts <100 cells/μl. Herpes simplex prophylaxis should be generally offered only to patients with a history of herpes simplex virus infection.作者: temperate 時(shí)間: 2025-3-24 22:35
https://doi.org/10.1007/978-1-4899-6333-8d in the general population. In patients with early favorable HL two cycles of ABVD followed by involved-field radiation (IF-RT) is considered standard of care. Patients with early unfavorable HL should receive four cycles of ABVD + IF-RT while six cycles of ABVD or six cycles of BEACOPP baseline should be given to patients with advanced HIV-HL.作者: 欲望 時(shí)間: 2025-3-25 02:53 作者: 沙漠 時(shí)間: 2025-3-25 07:17
HIV-Associated Hodgkin Lymphoma,d in the general population. In patients with early favorable HL two cycles of ABVD followed by involved-field radiation (IF-RT) is considered standard of care. Patients with early unfavorable HL should receive four cycles of ABVD + IF-RT while six cycles of ABVD or six cycles of BEACOPP baseline should be given to patients with advanced HIV-HL.作者: dandruff 時(shí)間: 2025-3-25 09:00
Myeloproliferative Neoplasms,ation, and their diagnosis is established after routine blood testing reveals an anomaly. Others present to medical attention complaining of headache, fatigue, weight loss, and early satiety in the backdrop of splenomegaly, bleeding, and thrombotic complications and clonal evolution.作者: Implicit 時(shí)間: 2025-3-25 14:54 作者: 討好美人 時(shí)間: 2025-3-25 17:19 作者: 縮減了 時(shí)間: 2025-3-25 20:46
https://doi.org/10.1007/978-3-319-26857-6AIDS; HIV-associated Hodgkin lymphoma; HIV-associated Non Hodgkin lymphoma; HIV-related hematological m作者: Hypopnea 時(shí)間: 2025-3-26 00:51 作者: CLEFT 時(shí)間: 2025-3-26 04:17 作者: Foam-Cells 時(shí)間: 2025-3-26 12:32 作者: Nonthreatening 時(shí)間: 2025-3-26 14:10 作者: 充氣球 時(shí)間: 2025-3-26 17:52 作者: –吃 時(shí)間: 2025-3-26 21:32 作者: 完全 時(shí)間: 2025-3-27 01:58 作者: forestry 時(shí)間: 2025-3-27 06:40
AIDS-Related Plasmablastic Lymphoma, called plasmablastic lymphoma (PBL). Its classification was prompted by its plasmacytoid appearance, with an elevated proliferation index, post-germinal phenotype with loss of the mature B cell markers, CD20, and strong expression of mature plasma cell antigens, i.e., CD138. The initial description作者: 惡臭 時(shí)間: 2025-3-27 13:20
HIV-Associated Primary Effusion Lymphoma,-8 DNA sequences were identified in eight lymphomas from HIV-infected patients. All eight, and only these eight, were body-cavity-based lymphomas as characterized by pleural, pericardial, and/or peritoneal lymphomatous effusions, defining an unusual subgroup of AIDS-associated B-cell lymphomas. They作者: 誘惑 時(shí)間: 2025-3-27 15:48
HIV and Indolent Lymphoma,ith the general population. Approximately 3 % of HIV/AIDS patients develop NHL. Among them, the risk increases with older age, duration of infection, and with a history of AIDS-defining events. Data supporting a decline in NHL in the post-HAART era are inconsistent. A prolonged immunocompromised sta作者: 提升 時(shí)間: 2025-3-27 18:53 作者: 走路左晃右晃 時(shí)間: 2025-3-28 01:39 作者: Adulterate 時(shí)間: 2025-3-28 03:47
Acute Lymphoblastic Leukemia,he spectrum and incidence of various neoplasms reported among persons infected with human immunodeficiency virus (HIV) has increased, and this emerging problem has contributed to the mortality of HIV-infected persons in the current era of potent antiretroviral therapy (ART). Large, population-based 作者: nominal 時(shí)間: 2025-3-28 07:05
Autologous Stem Cell Transplantation,herapy and/or radiation therapy to treat several hematologic and nonhematologic malignancies. High-dose chemotherapy (HDT) with ASCT is widely performed in HIV-negative patients with Hodgkin (HL) and non-Hodgkin lymphoma (NHL) and is standard therapy for refractory and relapsed patients, based on re作者: perpetual 時(shí)間: 2025-3-28 11:55
Allogeneic Stem Cell Transplantation, bone marrow transplantation. The early experience before combination antiretroviral therapy and modern supportive measures was disappointing. However, in recent years, many successful transplants have been reported. In one case, HIV cure has been reported (in a patient with an HIV-resistant donor).作者: Ballerina 時(shí)間: 2025-3-28 16:32 作者: Harness 時(shí)間: 2025-3-28 20:52
Myeloproliferative Neoplasms,DMs) and non-AIDS-defining malignancies (nADMs). One subset of these nADMs are myeloproliferative neoplasms (MPNs), in which there is an overproduction of red blood cells (RBCs), platelets, or a subset of white blood cells (WBCs). Many patients with MPNs are asymptomatic at the time of medical evalu作者: GRAZE 時(shí)間: 2025-3-28 23:44 作者: 教唆 時(shí)間: 2025-3-29 06:55 作者: mastoid-bone 時(shí)間: 2025-3-29 09:55 作者: 序曲 時(shí)間: 2025-3-29 13:03 作者: 粗魯性質(zhì) 時(shí)間: 2025-3-29 18:36
Introduction: Truth in Trouble,IV-associated lymphomas are specifically addressed in the WHO classification, HIV-related leukemias and myeloproliferative disorders are not. The 2008 WHO classification of malignant lymphoma distinguishes lymphoma also occurring in immunocompetent patients from those occurring more specifically in 作者: transdermal 時(shí)間: 2025-3-29 19:53 作者: Duodenitis 時(shí)間: 2025-3-30 00:12
Can There be a Private Language ?,gnoses in HIV-negative patients and 30–80 % in HIV-infected patients. Both plasmablastic lymphoma and primary CNS lymphoma are considered variants of DLBCL, but will be discussed in detail in separate chapters (Chaps. 5, Plasmablastic Lymphoma; and Chap. 7, Primary CNS Lymphoma). While in the era be作者: BURSA 時(shí)間: 2025-3-30 07:54
Problem Description and Fundamentals, observation of several children with multiple jaw tumours in Uganda, where he was working as a surgeon for the British government. These small round cell tumours were later recognised to be lymphomas. Burkitt defined a geographic ‘lymphoma belt’ with a high incidence of BL. The ‘lymphoma belt’ corr作者: 死亡率 時(shí)間: 2025-3-30 09:18 作者: PAC 時(shí)間: 2025-3-30 12:49
The Conception of God in the Later Royce-8 DNA sequences were identified in eight lymphomas from HIV-infected patients. All eight, and only these eight, were body-cavity-based lymphomas as characterized by pleural, pericardial, and/or peritoneal lymphomatous effusions, defining an unusual subgroup of AIDS-associated B-cell lymphomas. They作者: 不自然 時(shí)間: 2025-3-30 18:34
https://doi.org/10.1007/978-1-349-81652-1ith the general population. Approximately 3 % of HIV/AIDS patients develop NHL. Among them, the risk increases with older age, duration of infection, and with a history of AIDS-defining events. Data supporting a decline in NHL in the post-HAART era are inconsistent. A prolonged immunocompromised sta作者: 粗糙濫制 時(shí)間: 2025-3-30 21:33
https://doi.org/10.1007/978-1-4899-6333-8uency of advanced-stage disease and extranodal involvement are frequently encountered. Prior to the advent of combined antiretroviral therapy (cART), the prognosis of patients with HIV-HL was poor. However, with standard curative-intent therapy and modern cART, the outcome is similar to that reporte作者: 有偏見(jiàn) 時(shí)間: 2025-3-31 03:20 作者: 指派 時(shí)間: 2025-3-31 05:42
The Concise Encyclopedia of Statisticshe spectrum and incidence of various neoplasms reported among persons infected with human immunodeficiency virus (HIV) has increased, and this emerging problem has contributed to the mortality of HIV-infected persons in the current era of potent antiretroviral therapy (ART). Large, population-based 作者: STING 時(shí)間: 2025-3-31 10:10
https://doi.org/10.1007/978-1-4899-7096-1herapy and/or radiation therapy to treat several hematologic and nonhematologic malignancies. High-dose chemotherapy (HDT) with ASCT is widely performed in HIV-negative patients with Hodgkin (HL) and non-Hodgkin lymphoma (NHL) and is standard therapy for refractory and relapsed patients, based on re作者: 碌碌之人 時(shí)間: 2025-3-31 15:09
https://doi.org/10.1057/9780230608948 bone marrow transplantation. The early experience before combination antiretroviral therapy and modern supportive measures was disappointing. However, in recent years, many successful transplants have been reported. In one case, HIV cure has been reported (in a patient with an HIV-resistant donor).作者: Obedient 時(shí)間: 2025-3-31 17:59
https://doi.org/10.1007/978-94-017-3267-3tion. If a MG appears with a low M spike without other symptoms and signs, it is called MG of undetermined significance (MGUS). The prevalence of MG among HIV infected patients in the HAART era is 3–5 %..The pathophysiology of the development of a monoclonal gammopathy in the context of HIV is compl作者: FANG 時(shí)間: 2025-3-31 22:47 作者: allergy 時(shí)間: 2025-4-1 04:53
The Condition of England Questionrus-8 (HHV-8) infection. Interleukin-6 dysregulation is thought to be fundamental to its pathogenesis. MCD is characterized by recurrent flares with fever, lymphadenopathy, splenomegaly, and heterogeneous systemic manifestations, associated with cytopenia, raised inflammatory markers, and high HHV-8作者: duplicate 時(shí)間: 2025-4-1 07:45
https://doi.org/10.1007/978-3-030-02523-6 overall success of cART, hematological malignancies remain a common source of morbidity and mortality. In this chapter, we discuss the management of cART in relation to antineoplastic agents and potential pharmacological interactions between cART and antineoplastic agents and consider how to combin
